These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7359005)

  • 21. Effects of psoriatic patients' neutrophils and sera on angiogenic capability and natural cytotoxicity of normal human peripheral blood mononuclear cells.
    Majewski S; Wasik M; Jabłońska S; Tigałonowa M; Langner A
    Arch Immunol Ther Exp (Warsz); 1989; 37(3-4):465-70. PubMed ID: 2484151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transforming growth factor-beta differentially regulates the adhesiveness of normal and psoriatic dermal microvascular endothelial cells for peripheral blood mononuclear cells.
    Cai JP; Falanga V; Taylor JR; Chin YH
    J Invest Dermatol; 1992 Apr; 98(4):405-9. PubMed ID: 1548425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphocyte inhibition is compromised in mesenchymal stem cells from psoriatic skin.
    Liu R; Wang Y; Zhao X; Yang Y; Zhang K
    Eur J Dermatol; 2014; 24(5):560-7. PubMed ID: 25445090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered keratin 17 peptide ligands inhibit in vitro proliferation of keratinocytes and T cells isolated from patients with psoriasis.
    Shen Z; Chen L; Liu YF; Gao TW; Wang G; Fan XL; Fan JY; Fan PS; Li CY; Liu B; Dang YP; Li CX
    J Am Acad Dermatol; 2006 Jun; 54(6):992-1002. PubMed ID: 16713453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A suppressor lymphokine produced by human T leukemia cell lines. Partial characterization and spectrum of activity against normal and malignant hemopoietic cells.
    Santoli D; Tweardy DJ; Ferrero D; Kreider BL; Rovera G
    J Exp Med; 1986 Jan; 163(1):18-40. PubMed ID: 2416868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The autologous mixed epidermal cell-T lymphocyte reaction is elevated in psoriasis: a crucial role for epidermal HLA-DR+/CD1a- antigen-presenting cells.
    Prens EP; Benne K; van Joost T; Benner R
    J Invest Dermatol; 1991 Jun; 96(6):880-7. PubMed ID: 1710638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of immune system in the pathogenesis of psoriasis.
    Baadsgaard O; Fisher G; Voorhees JJ; Cooper KD
    J Invest Dermatol; 1990 Nov; 95(5 Suppl):32S-34S. PubMed ID: 16788627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis.
    Bhushan M; McLaughlin B; Weiss JB; Griffiths CE
    Br J Dermatol; 1999 Dec; 141(6):1054-60. PubMed ID: 10606852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of chloroquine on antigen-presenting functions of epidermal cells from normal and psoriatic skin.
    Demidem A; Taylor JR; Grammer SF; Streilein JW
    J Invest Dermatol; 1992 Feb; 98(2):181-6. PubMed ID: 1732381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitogenic effects of sera from normal and psoriatic subjects on human skin fibroblasts.
    Priestley GC; Adams LW
    Arch Dermatol Res; 1985; 277(1):13-5. PubMed ID: 3970584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antigen-independent expansion of T cells from psoriatic skin lesions: phenotypic characterization and antigen reactivity.
    Horrocks C; Holder JE; Berth-Jones J; Camp RD
    Br J Dermatol; 1997 Sep; 137(3):331-8. PubMed ID: 9349325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peripheral blood mononuclear cells proliferation and Th1/Th2 cytokine production in response to streptococcal M protein in psoriatic patients.
    Pérez-Lorenzo R; Núñez-Oreza LA; Garma-Quen PM; López-Pacheco E; Bricaire-Bricaire G
    Int J Dermatol; 2006 May; 45(5):547-53. PubMed ID: 16700789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of products of activated leukocytes (lymphokines and monokines) on the growth of malignant trophoblast cells in vitro.
    Berkowitz RS; Hill JA; Kurtz CB; Anderson DJ
    Am J Obstet Gynecol; 1988 Jan; 158(1):199-203. PubMed ID: 2447775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergy of B cell growth factor and interleukin 2 in the proliferation of activated human B cells.
    Romagnani S; Giudizi GM; Maggi E; Almerigogna F; Biagiotti R; Del Prete G; Mazzetti M; Alessi A; Vercelli D; Ricci M
    Eur J Immunol; 1985 Dec; 15(12):1158-64. PubMed ID: 3936718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human interleukin for DA cells (HILDA) does not affect the proliferation and differentiation of hematopoietic progenitor cells in human long-term bone marrow cultures.
    Schaafsma MR; Falkenburg JH; Duinkerken N; Moreau JF; Soulillou JP; Willemze R; Fibbe WE
    Exp Hematol; 1992 Jan; 20(1):6-10. PubMed ID: 1577095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood and lung mononuclear cell inhibition of fibroblast growth in sarcoidosis.
    Elias JA; Rossman MD; Daniele RP
    Am Rev Respir Dis; 1984 Dec; 130(6):1050-7. PubMed ID: 6508003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Up-regulation of Id1 in peripheral blood of psoriatic patients.
    Ronpirin C; Achariyakul M; Tencomnao T; Wongpiyabovorn J; Chaicumpa W
    Genet Mol Res; 2010 Nov; 9(4):2239-47. PubMed ID: 21086260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced proliferation and activation of peripheral blood mononuclear cells in patients with psoriasis vulgaris mediated by streptococcal antigen with bacterial DNA.
    Cai YH; Lu ZY; Shi RF; Xue F; Chen XY; Pan M; Yuan WR; Xu H; Li WP; Zheng J
    J Invest Dermatol; 2009 Nov; 129(11):2653-60. PubMed ID: 19609313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production of type-1 and type-2 cytokines by peripheral blood mononuclear cells of psoriatic patients.
    Mozzanica N; Cattaneo A; Trabattoni D; Finzi AF; Schmitt E; Ferrario E; Clerici M; Vignati G; Villa ML
    Immunology; 1995 Nov; 86(3):422-6. PubMed ID: 8550080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Xid mouse lymphocytes respond to TI-2 antigens when co-stimulated by TI-1 antigens or lymphokines.
    Couderc J; Février M; Duquenne C; Sourbier P; Liacopoulos P
    Immunology; 1987 May; 61(1):71-6. PubMed ID: 3294578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.